CBIO
Price
$12.00
Change
-$0.42 (-3.38%)
Updated
Aug 1 closing price
Capitalization
233.71M
UTHR
Price
$294.28
Change
+$19.58 (+7.13%)
Updated
Aug 1 closing price
Capitalization
13.31B
88 days until earnings call
Interact to see
Advertisement

CBIO vs UTHR

Header iconCBIO vs UTHR Comparison
Open Charts CBIO vs UTHRBanner chart's image
Crescent Biopharma
Price$12.00
Change-$0.42 (-3.38%)
Volume$68.16K
Capitalization233.71M
United Therapeutics
Price$294.28
Change+$19.58 (+7.13%)
Volume$2.43M
Capitalization13.31B
CBIO vs UTHR Comparison Chart in %
Loading...
CBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBIO vs. UTHR commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBIO is a Hold and UTHR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (CBIO: $12.00 vs. UTHR: $274.70)
Brand notoriety: CBIO and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBIO: 3% vs. UTHR: 117%
Market capitalization -- CBIO: $233.71M vs. UTHR: $13.31B
CBIO [@Biotechnology] is valued at $233.71M. UTHR’s [@Biotechnology] market capitalization is $13.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBIO’s FA Score shows that 3 FA rating(s) are green whileUTHR’s FA Score has 0 green FA rating(s).

  • CBIO’s FA Score: 3 green, 2 red.
  • UTHR’s FA Score: 0 green, 5 red.
According to our system of comparison, CBIO is a better buy in the long-term than UTHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBIO’s TA Score shows that 2 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • CBIO’s TA Score: 2 bullish, 4 bearish.
  • UTHR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than CBIO.

Price Growth

CBIO (@Biotechnology) experienced а -9.71% price change this week, while UTHR (@Biotechnology) price change was -10.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

CBIO is expected to report earnings on Jul 30, 2025.

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.3B) has a higher market cap than CBIO($234M). CBIO YTD gains are higher at: 4719.277 vs. UTHR (-16.597).
CBIOUTHRCBIO / UTHR
Capitalization234M13.3B2%
EBITDAN/A1.68B-
Gain YTD4719.277-16.597-28,435%
P/E RatioN/A11.48-
RevenueN/A2.99B-
Total CashN/A3.32B-
Total DebtN/A200M-
FUNDAMENTALS RATINGS
CBIO vs UTHR: Fundamental Ratings
CBIO
UTHR
OUTLOOK RATING
1..100
5361
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
3137
SMR RATING
1..100
9945
PRICE GROWTH RATING
1..100
3478
P/E GROWTH RATING
1..100
3280
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBIO's Valuation (17) in the Biotechnology industry is somewhat better than the same rating for UTHR (67) in the Pharmaceuticals Other industry. This means that CBIO’s stock grew somewhat faster than UTHR’s over the last 12 months.

CBIO's Profit vs Risk Rating (31) in the Biotechnology industry is in the same range as UTHR (37) in the Pharmaceuticals Other industry. This means that CBIO’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's SMR Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for CBIO (99) in the Biotechnology industry. This means that UTHR’s stock grew somewhat faster than CBIO’s over the last 12 months.

CBIO's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for UTHR (78) in the Pharmaceuticals Other industry. This means that CBIO’s stock grew somewhat faster than UTHR’s over the last 12 months.

CBIO's P/E Growth Rating (32) in the Biotechnology industry is somewhat better than the same rating for UTHR (80) in the Pharmaceuticals Other industry. This means that CBIO’s stock grew somewhat faster than UTHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBIOUTHR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
58%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
52%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MYY18.850.29
+1.56%
ProShares Short MidCap400
ASEA16.550.24
+1.46%
Global X FTSE Southeast Asia ETF
RSPS30.240.10
+0.32%
Invesco S&P 500® Eql Wt Cnsm Stapl ETF
GEM37.12-0.30
-0.80%
Goldman Sachs ActiveBeta® EMkts Eq ETF
DXUV54.48-0.95
-1.71%
Dimensional US Vector Equity ETF

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+7.13%
DAWN - UTHR
40%
Loosely correlated
-0.89%
MNKD - UTHR
39%
Loosely correlated
-0.79%
GERN - UTHR
39%
Loosely correlated
+1.74%
CBIO - UTHR
36%
Loosely correlated
-3.38%
INSM - UTHR
35%
Loosely correlated
+1.31%
More